篇名

基因改造人類的逐步實現:CRISPR用於人類胚胎基因編輯之探討   免費試閱

並列篇名

Human Gene Modification Takes Step Closer to Reality: A Discussion of CRISPR Gene Editing in Human Embryos

中文摘要

美國研究團隊使用基因編輯技術CRISPR改變大量單細胞胚胎DNA,完成美國首例人類胚胎基因改造試驗,美國國會目前仍傾向阻擋相關技術之臨床試驗。臺灣衛生福利部於2018年公告「再生醫療製劑管理條例(草案)」,希望能在促進病人權利之同時維護公共衛生,確保細胞及基因治療產品之品質、安全性及有效性,防止因使用該產品而引起傳染病之導入、傳播等問題。

英文摘要

An U.S. research team has conducted the first human embryo genetic modification experiment in the United States by changing the DNA of a large number of one- cell embryos with the gene-editing technique CRISPR. However, the US Congress still tends to block any clinical trial using related technology. The Ministry of Health and Welfare in Taiwan announced Regenerative Medicinal Products Derivatives Act (draft) in 2018 hoping to promote public health while promoting patient rights, ensuring the quality, safety and effectiveness of cell and gene therapy products, and to prevent the introduction and spread of infectious diseases by using those products.

起訖頁

145-154

出版單位
DOI

10.3966/241553062019050031012  複製DOI  DOI查詢

QRCode

下一篇
數位整合服務
產品服務
讀者服務專線:+886-2-23756688   傳真:+886-2-23318496   地址:臺北市館前路28號7樓

Copyright © 元照出版 All rights reserved. 版權所有,禁止轉貼節錄
TOP